EP2247257B1 - Teat needle with protective end wall - Google Patents

Teat needle with protective end wall Download PDF

Info

Publication number
EP2247257B1
EP2247257B1 EP09707392A EP09707392A EP2247257B1 EP 2247257 B1 EP2247257 B1 EP 2247257B1 EP 09707392 A EP09707392 A EP 09707392A EP 09707392 A EP09707392 A EP 09707392A EP 2247257 B1 EP2247257 B1 EP 2247257B1
Authority
EP
European Patent Office
Prior art keywords
teat
needle
needle shaft
canal
end wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP09707392A
Other languages
German (de)
French (fr)
Other versions
EP2247257A1 (en
Inventor
Peter-Jan Van Der Molen
Louis Van Vessem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helvoet Rubber and Plastic Technologies BV
Original Assignee
Helvoet Rubber and Plastic Technologies BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helvoet Rubber and Plastic Technologies BV filed Critical Helvoet Rubber and Plastic Technologies BV
Publication of EP2247257A1 publication Critical patent/EP2247257A1/en
Application granted granted Critical
Publication of EP2247257B1 publication Critical patent/EP2247257B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D1/00Surgical instruments for veterinary use
    • A61D1/02Trocars or cannulas for teats; Vaccination appliances

Definitions

  • the invention relates to a teat needle for administering an injection medium into a teat canal in the udder of a milking animal such as a cow or goat.
  • a similar teat needle is known from BE-1005479 , for example.
  • the teat needle has a thin tapering shaft that slides into the teat canal of the udder.
  • the length of the needle shaft is such that when it is fully inserted into the teat canal, a medicine or salve can be injected directly into the udder.
  • the teat needle is connected to a container that is filled with a specific quantity of the medicine or salve.
  • the teat needle delimits a through flow canal with a forward facing discharge opening.
  • the disadvantage of this is that ease of use and the animal-friendliness of the teat needle leaves to be desired. It may occur that when the needle shaft is inserted into the teat canal it meets a certain resistance. It may also be the case that the teat canal can suffer injury when the needle shaft is inserted. This happens especially if during manufacture membranes or burrs are left on the needle shaft on, for example, the discharge opening. There is a risk that these membranes or burrs will cut into the flesh internally. Wounds of this sort are painful for the animal and can lead to serious infection and to contamination of the milk that is withdrawn from the teat after treatment with the teat needle. Wounds of this sort also lead to financial loss for the farmer. In addition the discharge opening may get blocked during insertion into the teat canal. The needle shaft with its forward facing discharge opening scrapes free, as it were, all types of material that it encounters on the wall of the teat canal, and the material attempts to find a way into the interior of the flow canal via the discharge opening.
  • a teat needle is known from GB-914,131 .
  • This teat needle is designed for applying antibiotics to an infected and damaged teat canal, and if required can remain in the teat canal if this is deemed necessary for healing.
  • the needle shaft has both a forward facing discharge opening and a lateral facing discharge opening.
  • the lateral facing discharge opening reduces the problem of blockage, the forward facing discharge opening still has the above-mentioned disadvantages.
  • US 4,236,520 discloses a flexible fluid drain or injection tube for insertion into a teat of an animal's udder.
  • the injection tube comprises an elongated tubular body with an inlet opening at a bottom end part and a closed opposite end at an upper end part. The closed end is formed by a solid, rounded, tapered tip.
  • Inside the tubular body an axial bore is present which connects to the inlet opening.
  • two elongated slot-shaped outlet openings are present which connect to the bore. Those outlet openings are provided at axially different height positions along the tubular body and open out in opposite sideways directions.
  • the aim of the invention described below is to remove at least partially the above-mentioned disadvantages or to provide a usable alternative.
  • the aim of the invention is to create a user-friendly teat needle that is relatively cheap and simple to manufacture and which does not easily lead to wounding of the teat canal.
  • the teat needle comprises an elongated needle shaft with a distal end piece that slides into the teat canal.
  • a flow canal extends, which in the distal end piece connects to one or more laterally placed discharge openings.
  • a protective end wall is provided which at least partially closes off the flow canal in the forward direction.
  • This protective end wall is located here in the extension of the flow canal and thereby at least partially covers the distal end of the flow canal in the axial direction.
  • the protective end wall in combination with one or more laterally positioned discharge openings makes it advantageously possible during manufacture of the needle shaft as an injection moulding product to work with connecting mould cores within the outer circumference of the needle shaft.
  • one or more mould cores can be connected for the forming of the one or more outlet openings.
  • any membranes or burrs that remain after manufacture then advantageously come to lie on these transitions over the wall thickness of the needle shaft within the outer circumference of the needle shaft. There the membranes and burrs cannot, or can hardly, lead to injury to the animal on insertion into its teat canal.
  • the one or more laterally positioned discharge openings extend in an axial direction next to cut outs in the protective end wall.
  • the injection medium will not only be injected out of the needle shaft laterally, but also by being slightly directed forwards, flow into the teat.
  • this design makes it possible for the above mentioned mould cores to approach each other in an axial direction, during positioning in a mould cavity corresponding to the needle shaft, until the intended end position is reached, in which the mould cores partially come to rest against each other laterally at the transition(s) between the flow canals and the discharge opening(s).
  • At least two, in particular three, discharge openings are distributed laterally around the circumference of the needle shaft.
  • the protective end wall is integrally formed on the distal end section of the needle shaft.
  • the needle shaft can be manufactured from various materials, such as metal or plastic.
  • the needle shaft is preferably manufactured from plastic in an injection moulding process. If required the needle shaft can be assembled from various materials that can be prepared, for example, in a dual-component injection moulding process in one step.
  • the invention also relates to a method for the manufacture of the teat needle as well as the use of the teat needle.
  • the syringe 1 comprises a syringe body 2 with a cylindrical section 3 with an axial direction on which a distal end 3a and a proximal end 3b can be distinguished.
  • the syringe 1 comprises a piston element 5 with a piston rod 6 and a piston 7.
  • the free end of the piston rod 6 ends in a thumb support 8 and also has a cylindrical wall section.
  • the piston 7 is an integral part of the piston element 5 and is provided with two elastic deformable ring-shaped wall sections 11.
  • the piston 7 is dimensioned in such a way that in an assembled state it presses with its wall sections 11 to form a seal against the internal circumference of the cylindrical part 3.
  • the radial external dimensions of the piston 7 are basically the same as the radial internal dimensions of the cylindrical part 3.
  • the syringe 1 comprises an integrally formed assembly of a teat needle 12 that is connected to a break element 14 by means of weakened wall sections 13 (see also figure 6 and 7 ).
  • This assembly is designed to be broken during assembling, with the break element 14 and the teat needle 12 being connected successively in their respective end positions with the syringe body 2 (see figure 2 ).
  • break element 14 After assembling the break element 14 is designed to serve as a piston seal together with compressible cams provided on the piston rod 6.
  • the teat needle 12 is destined to form a nozzle on the distal end 3a and must be inserted into the syringe body 2 from the proximal end 3b. At the location of the distal end 3a the teat needle 12 can be firmly attached to the syringe body 2. In the embodiment shown this occurs by means of a snap connection with complimentary inter-gripping wall sections, in particular, a tongue groove connection (see figure 2 ).
  • the teat needle 12 comprises an elongated needle shaft 20 that is implemented here as a conical tapering distal end piece.
  • a conical tapering flow canal 21 extends in an axial direction.
  • the flow canal 21 discharges into three laterally positioned discharge openings 22 cut-out in the shaft wall that are symmetrically positioned around the circumference.
  • the tip of the teat needle 12 is provided with a protective end wall 24.
  • the protective wall 24 lies in the prolongation of the flow canal 21 and fully covers in the axial direction.
  • the protective wall 24 is integrally shaped with the needle shaft 20.
  • the discharge openings 22 extend in the axial direction into cut-outs 26 positioned sideways of the protective wall 24. In this way there is formed as it were a cylindrical core section 27 that is connected to the rest of the needle shaft 20 by ribs 28.
  • Both the core section 27 and the ribs 28 of the protective wall 24 are constructed with a radius, by which a rounded tip is obtained.
  • the teat needle 12 is made from plastic, especially PE, PP and/or TPE. If required parts of the teat needle 12, for example the needle shaft 20, the ribs 28 and the protective wall 24 with the respect to the rest of the teat needle 12 can be made from various materials that can be manufactured for example in a dual-component injection moulding process.
  • This nozzle seal 30 is here formed by a protective cap 31 that is formed integrally on the syringe body 2 by a weakened peripheral wall section 32.
  • the protective cap 31 is manufactured in two parts with the two parts 31a and 31b being connected together by a weakened peripheral wall section 33. The makes it possible to remove only the foremost part 31a, or also the rearmost part 31b. This gives the user the possibility to free up a longer or shorter part of the needle shaft 20 of the teat needle 12 for insertion in a body part.
  • the protective cap 31 of the nozzle seal 30 is constructed in such a way that with its front part 31 it lies sealing against the needle shaft 20 of the teat needle 12.
  • the protective cap 31 and the teat needle 12 are dimensioned in such a way that in the assembled state a small chamber is created between the tip of the teat needle 12 and the protective cap 31.
  • the protective cap 31 is designed with a basically cylindrical cavity or with a cavity that has a smaller cone angle than that of the needle shaft 20. This ensures that in the assembled state on the one hand a small chamber is formed around the tip while on the other hand a sealing takes place between the peripheral wall of the needle shaft 20 and the protective cap 31.
  • the various parts of the syringe can be given various forms and dimensions.
  • another type of tamper evident construction can also be applied to seal and/or close off the distal end in a reliable way.
  • the teat needle integrally onto the syringe body or use a teat needle that can be connected from the outside with the distal end of the syringe.
  • the teat needle freely in combination with another type of syringe or supply unit.
  • the discharge openings can also be provided at a lower level along the needle shaft and vary in number. The protective wall will then be able to spread over the entire tip.
  • a teat needle is provided that can be manufactured easily and cheaply and which lends itself very well to the introduction of an injection medium into the teat of an udder of a milking animal such as cow or goat, for example a salve with antibiotic qualities, or a curable medium that can seal the teat temporarily.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A teat needle (12) for the insertion of an injection medium in a teat canal in the udder of a milking animal, comprising an elongated needle shaft (20) with a distal end part that is slidable into the teat canal, and a flow canal (21) that extends in an axial direction through the needle shaft (20). The flow canal (21) in the distal end part connects to at least one laterally placed discharge opening (22) that is provided in a side wall of the distal end part of the needle shaft (20). The distal end part of the needle shaft (20) comprises a protective end wall (24) that lies in the prolongation of the flow canal (21) and which covers the flow canal (21) at least partially in the axial direction.

Description

  • The invention relates to a teat needle for administering an injection medium into a teat canal in the udder of a milking animal such as a cow or goat.
  • A similar teat needle is known from BE-1005479 , for example. The teat needle has a thin tapering shaft that slides into the teat canal of the udder. The length of the needle shaft is such that when it is fully inserted into the teat canal, a medicine or salve can be injected directly into the udder. The teat needle is connected to a container that is filled with a specific quantity of the medicine or salve. The teat needle delimits a through flow canal with a forward facing discharge opening.
  • The disadvantage of this is that ease of use and the animal-friendliness of the teat needle leaves to be desired. It may occur that when the needle shaft is inserted into the teat canal it meets a certain resistance. It may also be the case that the teat canal can suffer injury when the needle shaft is inserted. This happens especially if during manufacture membranes or burrs are left on the needle shaft on, for example, the discharge opening. There is a risk that these membranes or burrs will cut into the flesh internally. Wounds of this sort are painful for the animal and can lead to serious infection and to contamination of the milk that is withdrawn from the teat after treatment with the teat needle. Wounds of this sort also lead to financial loss for the farmer. In addition the discharge opening may get blocked during insertion into the teat canal. The needle shaft with its forward facing discharge opening scrapes free, as it were, all types of material that it encounters on the wall of the teat canal, and the material attempts to find a way into the interior of the flow canal via the discharge opening.
  • In addition a teat needle is known from GB-914,131 . This teat needle is designed for applying antibiotics to an infected and damaged teat canal, and if required can remain in the teat canal if this is deemed necessary for healing. In this case the needle shaft has both a forward facing discharge opening and a lateral facing discharge opening. Although the lateral facing discharge opening reduces the problem of blockage, the forward facing discharge opening still has the above-mentioned disadvantages.
  • US 4,236,520 discloses a flexible fluid drain or injection tube for insertion into a teat of an animal's udder. The injection tube comprises an elongated tubular body with an inlet opening at a bottom end part and a closed opposite end at an upper end part. The closed end is formed by a solid, rounded, tapered tip. Inside the tubular body an axial bore is present which connects to the inlet opening. Along a cylindrical section of the tubular body two elongated slot-shaped outlet openings are present which connect to the bore. Those outlet openings are provided at axially different height positions along the tubular body and open out in opposite sideways directions.
  • The injection tube of US 4,236,520 , upon which prior art the two part form of claim 1 is based, still leaves to be desired, in terms of manufacturing, animal friendliness and ease of use.
  • The aim of the invention described below is to remove at least partially the above-mentioned disadvantages or to provide a usable alternative. In particular the aim of the invention is to create a user-friendly teat needle that is relatively cheap and simple to manufacture and which does not easily lead to wounding of the teat canal.
  • This aim is achieved by a teat needle in accordance with claim 1. In this case the teat needle comprises an elongated needle shaft with a distal end piece that slides into the teat canal. Through the needle shaft in axial direction a flow canal extends, which in the distal end piece connects to one or more laterally placed discharge openings. A protective end wall is provided which at least partially closes off the flow canal in the forward direction. This protective end wall is located here in the extension of the flow canal and thereby at least partially covers the distal end of the flow canal in the axial direction. This has the advantage that a teat needle is obtained that can be manufactured with a protective end wall that connects to the needle shaft via gradual transition. Advantageously a punching or scraping action of the needle shaft can therefore be avoided. This diminishes the risk of blocking of the teat needle. In addition it simplifies the insertion of the needle shaft into the teat canal and prevents injury to the wall thereof.
  • The provision of the protective end wall in combination with one or more laterally positioned discharge openings makes it advantageously possible during manufacture of the needle shaft as an injection moulding product to work with connecting mould cores within the outer circumference of the needle shaft. In particular on the, for example, cylindrical or conical extending outer circumference wall of a mould core for the formation of the flow canal, one or more mould cores can be connected for the forming of the one or more outlet openings. As contact between the mould cores then takes place at the point of the transitions between the flow canal to be formed and the laterally placed discharge openings to be formed, any membranes or burrs that remain after manufacture then advantageously come to lie on these transitions over the wall thickness of the needle shaft within the outer circumference of the needle shaft. There the membranes and burrs cannot, or can hardly, lead to injury to the animal on insertion into its teat canal.
  • The one or more laterally positioned discharge openings extend in an axial direction next to cut outs in the protective end wall. During injection the injection medium will not only be injected out of the needle shaft laterally, but also by being slightly directed forwards, flow into the teat. In addition, this design makes it possible for the above mentioned mould cores to approach each other in an axial direction, during positioning in a mould cavity corresponding to the needle shaft, until the intended end position is reached, in which the mould cores partially come to rest against each other laterally at the transition(s) between the flow canals and the discharge opening(s).
  • In a preferred embodiment at least two, in particular three, discharge openings are distributed laterally around the circumference of the needle shaft. By providing these, moreover, symmetrically around the needle shaft, folding of the wall sections of the teat canal into the discharge openings towards the inside during insertion of the needle shaft can be prevented. This prevents that any membranes or burrs at the transitions of the flow canal to the discharge openings may still lead to injury.
  • In particular the protective end wall is integrally formed on the distal end section of the needle shaft. The needle shaft can be manufactured from various materials, such as metal or plastic. The needle shaft is preferably manufactured from plastic in an injection moulding process. If required the needle shaft can be assembled from various materials that can be prepared, for example, in a dual-component injection moulding process in one step.
  • Further preferred implementations are laid down in the sub-claims. The invention also relates to a method for the manufacture of the teat needle as well as the use of the teat needle.
  • The invention will be further explained using the attached drawings in which:
    • Fig. 1 is a schematic view in perspective of an embodiment of a syringe with teat needle in accordance with the invention before assembly;
    • Fig. 2 is a partially cut away view corresponding to figure 1 with a teat needle and break element incorporated into the syringe body;
    • Fig. 3 is a view corresponding to figure 2 with a piston element mounted in the syringe body;
    • Fig. 4 is a view corresponding to figure 2 with broken nozzle sealing and fully depressed piston element;
    • Fig. 5 is a partial view at a larger scale of figure 4;
    • Fig. 6 is an enlarged view of the assembly of teat needle with break element from figure 1; and
    • Fig. 7 is a partially exploded view of the teat needle in figure 6.
  • In figure 1 the entire syringe is given the reference numeral 1. The syringe 1 comprises a syringe body 2 with a cylindrical section 3 with an axial direction on which a distal end 3a and a proximal end 3b can be distinguished. In addition the syringe 1 comprises a piston element 5 with a piston rod 6 and a piston 7. The free end of the piston rod 6 ends in a thumb support 8 and also has a cylindrical wall section. The piston 7 is an integral part of the piston element 5 and is provided with two elastic deformable ring-shaped wall sections 11. The piston 7 is dimensioned in such a way that in an assembled state it presses with its wall sections 11 to form a seal against the internal circumference of the cylindrical part 3. In this respect the radial external dimensions of the piston 7 are basically the same as the radial internal dimensions of the cylindrical part 3.
  • As a further component preceding assembling, the syringe 1 comprises an integrally formed assembly of a teat needle 12 that is connected to a break element 14 by means of weakened wall sections 13 (see also figure 6 and 7). This assembly is designed to be broken during assembling, with the break element 14 and the teat needle 12 being connected successively in their respective end positions with the syringe body 2 (see figure 2).
  • After assembling the break element 14 is designed to serve as a piston seal together with compressible cams provided on the piston rod 6.
  • The teat needle 12 is destined to form a nozzle on the distal end 3a and must be inserted into the syringe body 2 from the proximal end 3b. At the location of the distal end 3a the teat needle 12 can be firmly attached to the syringe body 2. In the embodiment shown this occurs by means of a snap connection with complimentary inter-gripping wall sections, in particular, a tongue groove connection (see figure 2).
  • The teat needle 12 comprises an elongated needle shaft 20 that is implemented here as a conical tapering distal end piece. In the needle shaft 20 a conical tapering flow canal 21 extends in an axial direction. The flow canal 21 discharges into three laterally positioned discharge openings 22 cut-out in the shaft wall that are symmetrically positioned around the circumference.
  • According to the invention the tip of the teat needle 12 is provided with a protective end wall 24. The protective wall 24 lies in the prolongation of the flow canal 21 and fully covers in the axial direction. The protective wall 24 is integrally shaped with the needle shaft 20. The discharge openings 22 extend in the axial direction into cut-outs 26 positioned sideways of the protective wall 24. In this way there is formed as it were a cylindrical core section 27 that is connected to the rest of the needle shaft 20 by ribs 28.
  • Both the core section 27 and the ribs 28 of the protective wall 24 are constructed with a radius, by which a rounded tip is obtained.
  • The teat needle 12 is made from plastic, especially PE, PP and/or TPE. If required parts of the teat needle 12, for example the needle shaft 20, the ribs 28 and the protective wall 24 with the respect to the rest of the teat needle 12 can be made from various materials that can be manufactured for example in a dual-component injection moulding process.
  • On the distal end 3a of the syringe 2 a seal is provided of the nozzle formed by the teat needle 12. This nozzle seal 30 is here formed by a protective cap 31 that is formed integrally on the syringe body 2 by a weakened peripheral wall section 32. The protective cap 31 is manufactured in two parts with the two parts 31a and 31b being connected together by a weakened peripheral wall section 33. The makes it possible to remove only the foremost part 31a, or also the rearmost part 31b. This gives the user the possibility to free up a longer or shorter part of the needle shaft 20 of the teat needle 12 for insertion in a body part.
  • The protective cap 31 of the nozzle seal 30 is constructed in such a way that with its front part 31 it lies sealing against the needle shaft 20 of the teat needle 12. In addition the protective cap 31 and the teat needle 12 are dimensioned in such a way that in the assembled state a small chamber is created between the tip of the teat needle 12 and the protective cap 31. This has the advantage that a small quantity of injection medium can gather around the tip via the discharge openings 22 and/or the cut-outs 26, with the small quantity of injection medium after removal of the protective cap 31 serving directly as a friction reducing lubricant during insertion of the teat needle in, for example, the udder of an animal. The protective cap 31 is designed with a basically cylindrical cavity or with a cavity that has a smaller cone angle than that of the needle shaft 20. This ensures that in the assembled state on the one hand a small chamber is formed around the tip while on the other hand a sealing takes place between the peripheral wall of the needle shaft 20 and the protective cap 31.
  • In addition to the embodiments shown many other variants are possible. This means that the various parts of the syringe can be given various forms and dimensions. Instead of the integrally formed nozzle seal at the distal end another type of tamper evident construction can also be applied to seal and/or close off the distal end in a reliable way. In this way it is also possible to form the teat needle integrally onto the syringe body or use a teat needle that can be connected from the outside with the distal end of the syringe. It is also possible to use the teat needle freely in combination with another type of syringe or supply unit. The discharge openings can also be provided at a lower level along the needle shaft and vary in number. The protective wall will then be able to spread over the entire tip.
  • Thus according to the invention a teat needle is provided that can be manufactured easily and cheaply and which lends itself very well to the introduction of an injection medium into the teat of an udder of a milking animal such as cow or goat, for example a salve with antibiotic qualities, or a curable medium that can seal the teat temporarily.

Claims (14)

  1. Teat needle for insertion of an injection medium in a teat canal of the udder of a milking animal, comprising:
    - an elongated needle shaft (20) with a distal end piece that is slidable into the teat canal; and
    - a flow canal (21) that extends in an axial direction through the needle shaft (20);
    in which the flow canal (21) in the distal end part connects to at least one laterally placed discharge opening (22) that is provided in a side wall of the distal end piece of the needle shaft (20),
    in which the distal end piece of the needle shaft (20) comprises a protective end wall (24) that lies in the prolongation of the flow canal (21) and which covers the flow canal (21) at least partially in the axial direction,
    characterized in that
    the laterally placed discharge opening (22) continues in the axial direction into a cut-out (26) which is adjacent to the protective end wall (24).
  2. Teat needle according to claim 1, in which at least two laterally placed discharge openings (22) are distributed around the circumference of the needle shaft (20).
  3. Teat needle according to claim 2, in which at least three laterally placed discharge openings (22) are distributed around the circumference of the needle shaft (20).
  4. Teat needle according to claim 2 or 3, in which the discharge openings (22) are placed symmetrically around the circumference of the needle shaft (20).
  5. Teat needle according to one of the preceding claims, in which the at least one discharge opening (22) is provided at the transition between the protective end wall (24) and the side wall of the needle shaft (20).
  6. Teat needle according one of the claims 2-4 and 5, in which the discharge openings (22) are separated from each other by ribs (28) that extend between the protective end wall (24) and the side wall of the needle shaft (20).
  7. Teat needle according to one of the preceding claims, in which the protective end wall (24) has a radius.
  8. Teat needle according to one of the preceding claims, in which the transition between the protective end wall (24) and the side wall of the needle shaft (20) is rounded off.
  9. Teat needle according to one of the preceding claims, in which the needle shaft (20) is manufactured from plastic, in particular in an injection moulding process.
  10. Teat needle according to one of the preceding claims, in which the protective end wall (24) forms an integral part of the distal end piece of the needle shaft (20).
  11. Teat needle according to one of the preceding claims, in which the protective end wall (24) fully covers the flow canal (21) in the axial direction.
  12. Teat needle according to one of the preceding claims, in which the protective end wall (24) comprises a core element (27) that covers at least the center of the flow canal (21).
  13. Method for the manufacture of a teat needle (12) according to one of the preceding claims, comprising the following steps:
    - the placing in a mould cavity corresponding to the needle shaft (20), of a first mould core extending in an axial direction for keeping the flow canal (21) free;
    - the placing in the mould cavity corresponding to the needle shaft (20) of at least a second mould core for keeping at least one laterally placed discharge opening (22) free,
    in which the second mould core at the transition between the flow canal (21) and the laterally placed discharge opening (22) lies against a side wall of the first mould core, and
    in which the second mould core keeps free both the laterally placed discharge opening (22) as well as a cut-out (26) which is a continuation of the discharge opening (22) in the axial direction situated adjacent to the protective end wall (24).
  14. Method according to claim 13, in which the first and second mould core approach each other in the axial direction during placing in the mould cavity, and partially slide past each other until they have reached their respective end positions.
EP09707392A 2008-02-05 2009-01-22 Teat needle with protective end wall Not-in-force EP2247257B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2001259A NL2001259C1 (en) 2008-02-05 2008-02-05 Pacifier needle with end shield wall.
PCT/NL2009/000011 WO2009099320A1 (en) 2008-02-05 2009-01-22 Teat needle with protective end wall

Publications (2)

Publication Number Publication Date
EP2247257A1 EP2247257A1 (en) 2010-11-10
EP2247257B1 true EP2247257B1 (en) 2012-01-18

Family

ID=40512457

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09707392A Not-in-force EP2247257B1 (en) 2008-02-05 2009-01-22 Teat needle with protective end wall

Country Status (5)

Country Link
EP (1) EP2247257B1 (en)
AT (1) ATE541532T1 (en)
DK (1) DK2247257T3 (en)
NL (1) NL2001259C1 (en)
WO (1) WO2009099320A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1797339A (en) * 1927-12-10 1931-03-24 Gudmand-Hoyer Johannes Canule for cow teats
GB914131A (en) 1960-07-06 1962-12-28 Willows Francis Ltd Improved dilators
US4236520A (en) 1978-12-04 1980-12-02 Anderson Mark L Fluid drain or injection tube for an animal's udder
DE3363028D1 (en) * 1982-05-26 1986-05-22 Bruhl Wilhelm Haemorrhoid treatment stick
BE1005479A3 (en) 1991-10-31 1993-08-03 Backer Hubert Nv Sa De Veterinary INSTRUMENT FOR THE ADMINISTRATION OF MEDICINE.

Also Published As

Publication number Publication date
EP2247257A1 (en) 2010-11-10
WO2009099320A1 (en) 2009-08-13
DK2247257T3 (en) 2012-05-07
ATE541532T1 (en) 2012-02-15
NL2001259C1 (en) 2009-08-06

Similar Documents

Publication Publication Date Title
US5902277A (en) Low dead space, interchangeable needle syringe
CA2609966C (en) Aspiration catheter
CN104043186B (en) Conduit tube component with erasable device of blocking out blood flow and correlation technique
US20060085008A1 (en) Device for injecting bone cement
US20040122377A1 (en) Syringe delivery tip adapted to provide controlled flow rate
US7794421B2 (en) Aspirator sleeve and tip
EP3049146B1 (en) Needle-free connector
WO2008042299A2 (en) Detachable plunger rod syringe
WO2004096314A3 (en) Intracranial catheter assembly for precise treatment of brain tissue
CN104095665B (en) Membrane type ureteral calculus stops taking-up device
WO2005046779A3 (en) Cannulae having a redirecting tip
US20060212056A1 (en) Surgical instrument
AU2001250969A1 (en) Anesthesia conduction catheter
WO2006113869A3 (en) Internal cannulated joint for medical delivery systems
WO2004101052A3 (en) Catheter for uniform delivery of medication
US10994069B1 (en) Nozzle and ear cleaning device
CN111954509B (en) Device and method for cleaning external auditory canal
EP2747805B1 (en) Anti-clog suction tip apparatus
US5957928A (en) Handpiece for irrigation and aspiration during eye surgery and a method for manufacturing such a handpiece
AU2017282721B2 (en) Suction and irrigation apparatus
WO2014139038A1 (en) Surgical drainage tube assembly with concentric tubular members
EP2247257B1 (en) Teat needle with protective end wall
US20210085920A1 (en) Strain relief and methods of use thereof
WO2004054465A2 (en) Suction cap for aspiration instruments for medical/dental use
JPH0630172Y2 (en) Chemical injection device for dairy cows

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100826

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 541532

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120215

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602009004756

Country of ref document: DE

Effective date: 20120315

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20120118

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120418

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120418

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120419

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120518

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120131

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

26N No opposition filed

Effective date: 20121019

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009004756

Country of ref document: DE

Effective date: 20121019

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130131

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130131

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20131212

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120118

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20140128

Year of fee payment: 6

Ref country code: BE

Payment date: 20140127

Year of fee payment: 6

Ref country code: DE

Payment date: 20140127

Year of fee payment: 6

Ref country code: DK

Payment date: 20140130

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120122

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20140127

Year of fee payment: 6

Ref country code: FR

Payment date: 20140129

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20140129

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150131

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602009004756

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20150801

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20150131

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 541532

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150122

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20150122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150122

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150801

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20150930

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150122

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150131

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150122